Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
6.26
-0.14 (-2.19%)
At close: Jan 17, 2025, 4:00 PM
6.60
+0.34 (5.43%)
Pre-market: Jan 21, 2025, 7:55 AM EST
Pulmonx Employees
Pulmonx had 279 employees as of December 31, 2023. The number of employees increased by 10 or 3.72% compared to the previous year.
Employees
279
Change (1Y)
10
Growth (1Y)
3.72%
Revenue / Employee
$284,237
Profits / Employee
-$204,685
Market Cap
247.19M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 279 | 10 | 3.72% |
| Dec 31, 2022 | 269 | 16 | 6.32% |
| Dec 31, 2021 | 253 | 33 | 15.00% |
| Dec 31, 2020 | 220 | 40 | 22.22% |
| Dec 31, 2019 | 180 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
LUNG News
- 2 months ago - Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 2 months ago - Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers - Business Wire
- 2 months ago - Pulmonx to Present at the Stifel 2024 Healthcare Conference - GlobeNewsWire
- 2 months ago - Pulmonx Corporation (LUNG) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024 - GlobeNewsWire
- 4 months ago - Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024 - GlobeNewsWire
- 5 months ago - Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference - GlobeNewsWire
- 5 months ago - Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference - GlobeNewsWire